1.
High Blood Press Cardiovasc Prev
; 26(2): 85-100, 2019 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30877603
RESUMO
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. Despite the clinical long-term and near-term benefits of lowering cholesterol in, respectively, primary and secondary prevention of ASCVD, cholesterol levels remain under-treated, with many patients not achieving their recommended targets. The present article will review the latest updates on lipid management with emphases on the different classes of cholesterol-lowering agents and their clinical uses.